Gian Battista Danzi
A5101433364- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- COVID-19 Clinical Research Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Valve Diseases and Treatments
- Peripheral Artery Disease Management
- Long-Term Effects of COVID-19
- COVID-19 and healthcare impacts
- Cerebrovascular and Carotid Artery Diseases
- Venous Thromboembolism Diagnosis and Management
- Cardiac Structural Anomalies and Repair
- Cardiac, Anesthesia and Surgical Outcomes
- Vascular Procedures and Complications
- Aortic aneurysm repair treatments
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
- Atrial Fibrillation Management and Outcomes
- Transplantation: Methods and Outcomes
- Coronary Artery Anomalies
- Mechanical Circulatory Support Devices
- SARS-CoV-2 and COVID-19 Research
- Congenital Heart Disease Studies
- Cardiovascular Disease and Adiposity
- Peripheral Nerve Disorders
Istituti Ospitalieri di Cremona
2020-2024
Hospital das Clínicas da Universidade Federal de Pernambuco
2023
Azienda Socio Sanitaria Territoriale di Cremona
2020-2022
Ospedale Maggiore
2009-2022
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
1993-2021
Azienda Ospedaliera Ospedale Maggiore
2021
Ospedale Santa Corona
2013-2020
Istituti di Ricovero e Cura a Carattere Scientifico
1995-2020
University of Padua
2002-2020
Policlinico San Matteo Fondazione
2020
oronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is causing a dramatic pandemic. 1ombardy, in northern Italy, one of the most affected regions worldwide. 2ardiovascular complications occur frequently patients with COVID-19, 3 challenges management.We aimed to evaluate incidence, clinical presentation, angiographic findings, and outcomes ST-elevation myocardial infarction (STEMI) COVID-19.All hospitals catherization laboratories...
Abstract Aims An increase in out-of-hospital cardiac arrest (OHCA) incidence has been reported the very early phase of COVID-19 epidemic, but a clear demonstration correlation between increased OHCA and is missing so far. We aimed to verify whether there an association difference compared with 2019 epidemic curve. Methods results included all consecutive OHCAs which occurred Provinces Lodi, Cremona, Pavia, Mantova 2 months following first documented case Lombardia Region them those same time...
<h3>Importance</h3> Myocardial injury, detected by elevated plasma troponin levels, has been associated with mortality in patients hospitalized coronavirus disease 2019 (COVID-19). However, the initial data were reported from single-center or 2-center studies Chinese populations. Compared these patients, European and US are older, more comorbidities higher rates. <h3>Objective</h3> To evaluate prevalence prognostic value of myocardial a large population White Italian COVID-19. <h3>Design,...
Background The aim of this prospective, multicenter study was the identification Doppler flow velocity measurements predictive clinical outcome patients undergoing single-vessel balloon angioplasty with no previous Q-wave myocardial infarction. Methods and Results In 297 patients, a guidewire used to measure basal maximal hyperemic velocities proximal distal stenosis before after angioplasty. 225 an angiographically successful percutaneous transluminal coronary (PTCA), postprocedural reserve...
Abstract Introduction A hypercoagulable condition was described in patients with coronavirus disease 2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing to progression lethality. Aim We evaluated if in-hospital administration of heparin improved survival large cohort Italian COVID-19 patients. Methods In retrospective observational study, 2,574 unselected hospitalized 30 clinical centers Italy from February 19, 2020 June 5, laboratory-confirmed severe acute...
Abstract Aims To assess the clinical relevance of a history atrial fibrillation (AF) in hospitalized patients with coronavirus disease 2019 (COVID-19). Methods and results We enrolled 696 consecutive (mean age 67.4 ± 13.2 years, 69.7% males) admitted for COVID-19 13 Italian cardiology centres between 1 March 9 April 2020. One hundred six (15%) had AF median hospitalization length was 14 days (interquartile range 9–24). Patients were older higher burden cardiovascular risk factors. Compared...
Several studies reported a high incidence of pulmonary embolism (PE) among patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, but detailed data about clinical characteristics, risk factors these and prognostic role PE are still lacking. We aim to evaluate the occurrence SARS-CoV-2 describe their factors, in-hospital outcomes.This is multicenter Italian study including 333 consecutive admitted seven hospitals from February 22 May 15, 2020. All underwent...
3% of kidney transplant recipients return to dialysis annually upon allograft failure. Development antibodies (Ab) against human leukocyte antigens (HLA) is a validated prognostic biomarker We tested whether screening for HLA Ab, combined with an intervention improve adherence and optimization immunosuppression could prevent failure.Prospective, open-labelled randomised biomarker-based strategy (hybrid) trial in 13 UK centres [EudraCT (2012-004308-36) ISRCTN (46157828)]. Patients were...
Abstract Background Pulmonary embolism (PE) has been described in coronavirus disease 2019 (COVID-19) critically ill patients, but the evidence from more heterogeneous cohorts is limited. Methods Data were retrospectively obtained consecutive COVID-19 patients admitted to 13 Cardiology Units Italy, March 1st April 9th, 2020, and followed until in-hospital death, discharge, or 23rd, 2020. The association of baseline variables with computed tomography-confirmed PE was investigated by Cox...
Previous studies for approved indications (on-label) have shown the good safety and efficacy profiles of Nobori DES. We conducted a prospective, multicentre study to validate clinical performance this stent in real-world setting.A total 3,067 consecutive patients undergoing percutaneous coronary intervention with DES were enrolled NOBORI 2 registry. At one two years, 97% 95% patients, respectively, available follow-up. The rates target lesion failure (TLF), cardiac death, myocardial...